Related Experiment Video
Updated: May 10, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neurodevelopmental outcome of extremely low birth weight infants with Candida infection
Ira Adams-Chapman1, Carla M Bann, Abhik Das
1Department of Pediatrics, Emory University, Atlanta, GA.
Insights
Candida infections in extremely low birth weight (ELBW) infants increase the risk of death and neurodevelopmental impairment (NDI). This risk is highest for infants with Candida sepsis or meningitis.
Area of Science:
- Neonatal Research
- Infectious Diseases
- Pediatric Neurology
Background:
- Candida infections pose a significant threat to preterm infants, particularly those with extremely low birth weight (ELBW).
- Late-onset sepsis in ELBW infants is associated with adverse outcomes, including mortality and neurodevelopmental impairment (NDI).
Purpose of the Study:
- To evaluate the mortality and neurodevelopmental outcomes of ELBW infants based on their infection status in the Candida study.
- To compare outcomes between infected and uninfected ELBW infants and with a control group not screened for sepsis.
Main Methods:
- Retrospective analysis of ELBW infants (born 2004-2007) enrolled in the Neonatal Research Network (NRN) Candida study.
- Neurodevelopmental impairment assessed at 18 months using Bayley Scales of Infant Development-II or -III.
- Comparison with a control group from the NRN Generic Database not screened for sepsis.
Main Results:
- Among ELBW infants in the Candida study, 31% with Candida sepsis and 31% with non-Candida sepsis experienced NDI.
- Candida sepsis or meningitis increased the risk of death and the composite outcome of death and/or NDI.
- Candida infection was associated with a higher likelihood of NDI compared to infants never screened for sepsis (OR 1.83).
Conclusions:
- ELBW infants with any sepsis or meningitis face elevated risks of death and NDI.
- Candida sepsis and/or meningitis present the highest risk for adverse outcomes in this vulnerable population.
Objective:
Candida remains an important cause of late-onset infection in preterm infants. Mortality and neurodevelopmental outcome of extremely low birth weight (ELBW) infants enrolled in the Candida study were evaluated based on infection status.
Study Design:
ELBW infants born at Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN) centers between March 2004 and July 2007 who were screened for suspected sepsis were eligible for inclusion in the Candida study. Primary outcome data for neurodevelopmental impairment (NDI) or death were available for 1317 of the 1515 infants (87%) enrolled in the Candida study. The Bayley Scales of Infant Development-II or -III was administered at 18 months' adjusted age. A secondary comparison was performed with 864 infants enrolled in the NRN Generic Database during the same cohort who were never screened for sepsis and therefore not eligible for the Candida study.
Results:
Among ELBW infants enrolled in the Candida study, 31% with Candida and 31% with late-onset non-Candida sepsis had NDI at 18 months. Infants with Candida sepsis and/or meningitis had an increased risk of death and were more likely to have the composite outcome of death and/or NDI compared with uninfected infants in adjusted analysis. Compared with infants in the NRN registry never screened for sepsis, overall risk for death were similar but those with Candida infection were more likely to have NDI (OR 1.83, 95% CI 1.01-3.33, P = .047).
Conclusions:
In this cohort of ELBW infants, those with infection and/or meningitis were at increased risk for death and/or NDI. This risk was highest among those with Candida sepsis and/or meningitis.
Related Concept Videos
Development of the Oral Microbiota
Fungal Phylum Microsporidia
Development of Human Microbiota
Cytomegalovirus Disease
